Supira Medical
Supira Medical is developing a next-generation percutaneous ventricular assist device .
Launch date
Employees
Market cap
-
Enterprise valuation
€145—218m (Dealroom.co estimates Nov 2023.)
Campbell California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$15.5m | Series A | ||
$35.0m | Series B | ||
* | $30.0m Valuation: $175m | Series C | |
* | $40.0m | Series D | |
| Total Funding | €110m | ||
Recent News about Supira Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.